Emerald Who's Who for Executives and Professionals

Products

Eric A. Floyd
Vice President Worldwide regulatory Affairs
Cephalon, Inc.

41 Moores Road
2W-163
Frazer, PA 19335
USA

Email:   efloyd@cephalon.com
URL:   www.cephalon.com
Type of Business:   Biotechnology and Pharmaceutical
Expertise:   Regulatory Affairs
Marketing Area:   International
Education/Degrees:   B.S., M.S., M.B.A., Ph.D. - Meharry Medical College
Affiliations:   SOCIETY MEMBERSHIPS - American Chemical Society, American Medical Writers’ Association, American Physiological Society, Histochemical Society, Research Society on Alcoholism, Sigma Xi, Society for Neuroscience, Drug Information Association, Regulatory Affairs Professionals Society, Pharmaceutical Education and Research Institute, PHARMA
Awards:   ACADEMIC AND PROFESSIONAL HONORS 1995-1997 Howard Hughes Postdoctoral Research Fellowship 1994-1995 Ford Foundation Dissertation Fellowship 1992-1994 Patricia Roberts Harris Predoctoral Fellowship 1990-1992 Porter Physiology Fellowship/American Physiological Society
Favorite Publication:   Wall Street Journal, NY Times, Pharmaceutical Executive
Biography:   Dr. Eric Floyd is currently the Vice President of Worldwide Regulatory Affairs at Cephalon, Inc. He serves as the senior company advisor and liaison with government regulators, most significantly with the FDA, EMEA, sFDA, and other key health authorities for Cephalon, Inc. on regulatory matters. His key responsibilities include providing strategy and direction regarding the regulatory oversight of Cephalon investigational and marketed products as well as developing long-term company-wide regulatory strategies and operating principles/practices. Prior to joining Cephalon, Dr. Floyd was Vice President & Global Head for Respiratory, Dermatology, and Tropical Medicines - Drug Regulatory Affairs at Novartis Pharmaceutical Corporation. He was responsible for the development and marketed products globally (US, Europe, Japan, and ROW) and directed the regulatory strategies and support for therapeutic-specific development compounds (registration) and marketed products (life cycle management) within the Novartis Pharma therapeutic portfolio. Dr. Floyd held previous regulatory roles at Merck, Bristol Myers Squibb, and Aventis Pharmaceuticals. Dr. Floyd serves as an adjunct faculty member in the Department of Neuroscience at Harvard Medical School, Drexel University school of Medicine, and Wake Forest University School of Medicine. He also is a member of the board of trustees at Meharry Medical College and the University of Illinois. Dr. Floyd completed his undergraduate degree in Bioengineering from the University of Illinois, a Masters degree in Neuroscience from Tennessee State University, a Doctorate in Neurophysiology from Meharry Medical College, an Executive MBA in Pharmaceutical Marketing from Saint Josephs University, and completed certification in International Business from the Insead–Wharton Business School alliance in Fountainebleu, France.


Click here to see a full listing of premiere members.

Email:	efloyd@cephalon.com
URL:	www.cephalon.com
Type of Business:	Biotechnology and Pharmaceutical
Expertise:	Regulatory Affairs
Marketing Area:	International
Education/Degrees:	B.S., M.S., M.B.A., Ph.D. - Meharry Medical College
Affiliations:	SOCIETY MEMBERSHIPS - American Chemical Society, American Medical Writers’ Association, American Physiological Society, Histochemical Society, Research Society on Alcoholism, Sigma Xi, Society for Neuroscience, Drug Information Association, Regulatory Affairs Professionals Society, Pharmaceutical Education and Research Institute, PHARMA
Awards:	ACADEMIC AND PROFESSIONAL HONORS 1995-1997 Howard Hughes Postdoctoral Research Fellowship 1994-1995 Ford Foundation Dissertation Fellowship 1992-1994 Patricia Roberts Harris Predoctoral Fellowship 1990-1992 Porter Physiology Fellowship/American Physiological Society
Favorite Publication:	Wall Street Journal, NY Times, Pharmaceutical Executive
Biography:	Dr. Eric Floyd is currently the Vice President of Worldwide Regulatory Affairs at Cephalon, Inc. He serves as the senior company advisor and liaison with government regulators, most significantly with the FDA, EMEA, sFDA, and other key health authorities for Cephalon, Inc. on regulatory matters. His key responsibilities include providing strategy and direction regarding the regulatory oversight of Cephalon investigational and marketed products as well as developing long-term company-wide regulatory strategies and operating principles/practices. Prior to joining Cephalon, Dr. Floyd was Vice President & Global Head for Respiratory, Dermatology, and Tropical Medicines - Drug Regulatory Affairs at Novartis Pharmaceutical Corporation. He was responsible for the development and marketed products globally (US, Europe, Japan, and ROW) and directed the regulatory strategies and support for therapeutic-specific development compounds (registration) and marketed products (life cycle management) within the Novartis Pharma therapeutic portfolio. Dr. Floyd held previous regulatory roles at Merck, Bristol Myers Squibb, and Aventis Pharmaceuticals. Dr. Floyd serves as an adjunct faculty member in the Department of Neuroscience at Harvard Medical School, Drexel University school of Medicine, and Wake Forest University School of Medicine. He also is a member of the board of trustees at Meharry Medical College and the University of Illinois. Dr. Floyd completed his undergraduate degree in Bioengineering from the University of Illinois, a Masters degree in Neuroscience from Tennessee State University, a Doctorate in Neurophysiology from Meharry Medical College, an Executive MBA in Pharmaceutical Marketing from Saint Josephs University, and completed certification in International Business from the Insead–Wharton Business School alliance in Fountainebleu, France.